Results 71 to 80 of about 273 (101)

A strategy to re-sensitise drug-resistant Gram-positive bacteria to oxazolidinone-class antibiotics. [PDF]

open access: yesEBioMedicine
Zhang Q   +11 more
europepmc   +1 more source

Neuromyelitis optica causing vision loss during TB treatment with sutezolid: evidence of aberrant immunity following infection. [PDF]

open access: yesIJTLD Open
Glover NA   +13 more
europepmc   +1 more source

Recent Progress and Challenges for Drug-Resistant Tuberculosis Treatment. [PDF]

open access: yesPharmaceutics, 2021
Stephanie F, Saragih M, Tambunan USF.
europepmc   +1 more source

Delpazolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-DECODE-01): a prospective, randomised, open-label, phase 2b, dose-finding trial

open access: yesThe Lancet Infectious Diseases
Lilian Tina Minja   +105 more
openaire   +1 more source

Durable three-year outcomes and persistent neuropathy following nine-month all-oral regimens for rifampicin-resistant tuberculosis: a multicentre cohort study in China. [PDF]

open access: yesBMC Infect Dis
Fu L   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy